Cardiol Therapeutics Inc. SEC filings CRDL
Cardiol Therapeutics Inc. has 188 filings in SEC EDGAR's recent list, going back to Mar 29, 2017. Its latest annual report, Form 40-F, was filed on Mar 31, 2026 for the period ended Dec 31, 2025. The most recent current report (Form 6-K) was filed on Nov 3, 2026. The company's fiscal year ends on December 31.
| Form | Description | Filed | Period |
|---|---|---|---|
| 6-K | Current report (foreign issuer) | Nov 3, 2026 | Nov 3, 2026 |
| 6-K | Current report (foreign issuer) | Nov 3, 2026 | Nov 3, 2026 |
| SUPPL | Filing | Nov 3, 2026 | — |
| 6-K | Current report (foreign issuer) | Sep 23, 2026 | Sep 23, 2026 |
| SUPPL | Filing | Sep 16, 2026 | — |
| F-10/A | Filing | Sep 16, 2026 | — |
| 6-K | Current report (foreign issuer) | Sep 16, 2026 | Sep 16, 2026 |
| 6-K | Current report (foreign issuer) | Sep 15, 2026 | Sep 14, 2026 |
| 6-K | Current report (foreign issuer) | Sep 11, 2026 | Sep 10, 2026 |
| 6-K | Current report (foreign issuer) | Sep 10, 2026 | Sep 10, 2026 |
| F-X | Filing | Sep 10, 2026 | — |
| F-10 | Filing | Sep 10, 2026 | — |
| 6-K | Current report (foreign issuer) | Sep 9, 2026 | Sep 9, 2026 |
| 6-K | Current report (foreign issuer) | Aug 12, 2026 | Jun 30, 2026 |
| 6-K | Current report (foreign issuer) | Aug 5, 2026 | Aug 5, 2026 |
| 6-K | Current report (foreign issuer) | Jul 14, 2026 | Jul 14, 2026 |
| 6-K | Current report (foreign issuer) | Jul 9, 2026 | Jul 9, 2026 |
| 6-K | Current report (foreign issuer) | Jun 25, 2026 | Jun 25, 2026 |
| 6-K | Current report (foreign issuer) | Jun 23, 2026 | Jun 23, 2026 |
| 6-K | Current report (foreign issuer) | May 26, 2026 | May 25, 2026 |
| 6-K | Current report (foreign issuer) | May 14, 2026 | May 14, 2026 |
| 6-K | Current report (foreign issuer) | May 11, 2026 | Mar 31, 2026 |
| 6-K | Current report (foreign issuer) | May 7, 2026 | May 7, 2026 |
| 6-K | Current report (foreign issuer) | Apr 28, 2026 | Apr 28, 2026 |
| 6-K | Current report (foreign issuer) | Apr 14, 2026 | Apr 14, 2026 |
| 6-K | Current report (foreign issuer) | Apr 10, 2026 | Apr 10, 2026 |
| 6-K | Current report (foreign issuer) | Apr 1, 2026 | Apr 1, 2026 |
| 40-F | Annual report (Canadian issuer) | Mar 31, 2026 | Dec 31, 2025 |
| 6-K | Current report (foreign issuer) | Feb 25, 2026 | Feb 25, 2026 |
| 6-K | Current report (foreign issuer) | Feb 10, 2026 | Feb 10, 2026 |
| 6-K | Current report (foreign issuer) | Feb 2, 2026 | Jan 23, 2026 |
| 6-K | Current report (foreign issuer) | Jan 26, 2026 | Jan 26, 2026 |
| 6-K | Current report (foreign issuer) | Jan 23, 2026 | Jan 23, 2026 |
| 6-K | Current report (foreign issuer) | Jan 16, 2026 | Jan 16, 2026 |
| 6-K | Current report (foreign issuer) | Jan 13, 2026 | Jan 13, 2026 |
| 6-K | Current report (foreign issuer) | Dec 1, 2025 | Dec 1, 2025 |
| 6-K | Current report (foreign issuer) | Nov 13, 2025 | Sep 30, 2025 |
| 6-K | Current report (foreign issuer) | Nov 13, 2025 | Nov 13, 2025 |
| SUPPL | Filing | Nov 5, 2025 | — |
| F-X | Filing | Nov 5, 2025 | — |
| F-10 | Form f-10 | Nov 5, 2025 | — |
| 6-K | Current report (foreign issuer) | Nov 5, 2025 | Nov 5, 2025 |
| D | Filing | Nov 4, 2025 | — |
| 6-K | Current report (foreign issuer) | Oct 28, 2025 | Oct 27, 2025 |
| 6-K | Current report (foreign issuer) | Oct 27, 2025 | Oct 27, 2025 |
| 6-K | Current report (foreign issuer) | Oct 21, 2025 | Oct 21, 2025 |
| 6-K | Current report (foreign issuer) | Oct 17, 2025 | Oct 17, 2025 |
| 6-K | Current report (foreign issuer) | Aug 14, 2025 | Jun 30, 2025 |
| 6-K | Current report (foreign issuer) | Aug 11, 2025 | Aug 11, 2025 |
| 6-K | Current report (foreign issuer) | Aug 6, 2025 | Aug 6, 2025 |
| 6-K | Current report (foreign issuer) | Jul 22, 2025 | Jul 22, 2025 |
| 6-K | Current report (foreign issuer) | May 29, 2025 | May 29, 2025 |
| 6-K | Current report (foreign issuer) | May 27, 2025 | May 27, 2025 |
| 6-K | Current report (foreign issuer) | May 14, 2025 | Mar 31, 2025 |
| 6-K | Current report (foreign issuer) | Apr 29, 2025 | Apr 29, 2025 |
| 6-K | Current report (foreign issuer) | Apr 28, 2025 | Dec 31, 2024 |
| 6-K | Current report (foreign issuer) | Apr 16, 2025 | Apr 16, 2025 |
| 6-K | Current report (foreign issuer) | Apr 1, 2025 | Apr 1, 2025 |
| 40-F | Annual report (Canadian issuer) | Mar 31, 2025 | Dec 31, 2024 |
| 6-K | Current report (foreign issuer) | Mar 14, 2025 | Mar 14, 2025 |
| 6-K | Current report (foreign issuer) | Mar 3, 2025 | Mar 3, 2025 |
| 6-K | Current report (foreign issuer) | Feb 20, 2025 | Feb 20, 2025 |
| 6-K | Current report (foreign issuer) | Feb 4, 2025 | Feb 4, 2025 |
| 6-K | Current report (foreign issuer) | Nov 18, 2024 | Nov 18, 2024 |
| 6-K | Current report (foreign issuer) | Nov 14, 2024 | Sep 30, 2024 |
| 6-K | Current report (foreign issuer) | Oct 22, 2024 | Oct 22, 2024 |
| 6-K | Current report (foreign issuer) | Oct 11, 2024 | Oct 11, 2024 |
| 6-K | Current report (foreign issuer) | Oct 10, 2024 | Oct 10, 2024 |
| SUPPL | Filing | Oct 9, 2024 | — |
| 6-K | Current report (foreign issuer) | Oct 9, 2024 | Oct 9, 2024 |
| 6-K | Current report (foreign issuer) | Oct 8, 2024 | Oct 8, 2024 |
| SUPPL | Filing | Oct 8, 2024 | — |
| 6-K | Current report (foreign issuer) | Sep 24, 2024 | Sep 24, 2024 |
| 6-K | Current report (foreign issuer) | Sep 10, 2024 | Sep 10, 2024 |
| 6-K | Current report (foreign issuer) | Aug 12, 2024 | Jun 30, 2024 |
| EFFECT | Filing | Jul 16, 2024 | — |
| 6-K | Current report (foreign issuer) | Jul 16, 2024 | Jul 16, 2024 |
| SUPPL | Filing | Jul 16, 2024 | — |
| F-10/A | Filing | Jul 12, 2024 | — |
| F-X | Form f-x | Jul 8, 2024 | — |
| F-10 | Filing | Jul 5, 2024 | — |
| 6-K | Current report (foreign issuer) | Jun 27, 2024 | Jun 27, 2024 |
| 6-K | Current report (foreign issuer) | Jun 25, 2024 | Jun 25, 2024 |
| 6-K | Current report (foreign issuer) | Jun 13, 2024 | Jun 13, 2024 |
| 6-K | Current report (foreign issuer) | May 28, 2024 | Dec 31, 2023 |
| 6-K | Current report (foreign issuer) | May 14, 2024 | Mar 31, 2024 |
| 6-K | Current report (foreign issuer) | May 14, 2024 | May 14, 2024 |
| 6-K | Current report (foreign issuer) | Apr 26, 2024 | Apr 18, 2024 |
| 6-K | Current report (foreign issuer) | Apr 2, 2024 | Apr 2, 2024 |
| 20-F | Annual report (foreign issuer) | Apr 1, 2024 | Dec 31, 2023 |
| 6-K | Current report (foreign issuer) | Feb 26, 2024 | Feb 26, 2024 |
| 6-K | Current report (foreign issuer) | Feb 21, 2024 | Feb 21, 2024 |
| 6-K | Current report (foreign issuer) | Feb 15, 2024 | Feb 15, 2024 |
| 6-K | Current report (foreign issuer) | Jan 24, 2024 | Jan 24, 2024 |
| 6-K | Current report (foreign issuer) | Jan 9, 2024 | Jan 9, 2024 |
| 6-K | Current report (foreign issuer) | Dec 5, 2023 | Dec 5, 2023 |
| 6-K | Current report (foreign issuer) | Nov 16, 2023 | Nov 16, 2023 |
| 6-K | Current report (foreign issuer) | Nov 14, 2023 | Sep 30, 2023 |
| 6-K | Current report (foreign issuer) | Nov 1, 2023 | Nov 1, 2023 |
| 6-K | Current report (foreign issuer) | Oct 20, 2023 | Oct 20, 2023 |
| 6-K | Current report (foreign issuer) | Oct 11, 2023 | Oct 11, 2023 |
| 6-K | Current report (foreign issuer) | Oct 10, 2023 | Oct 10, 2023 |
| 6-K | Current report (foreign issuer) | Sep 26, 2023 | Sep 26, 2023 |
| 6-K | Current report (foreign issuer) | Sep 20, 2023 | Sep 20, 2023 |
| 6-K | Current report (foreign issuer) | Sep 19, 2023 | Sep 19, 2023 |
| 6-K | Current report (foreign issuer) | Aug 10, 2023 | Jun 30, 2023 |
| 6-K | Current report (foreign issuer) | Aug 9, 2023 | Aug 9, 2023 |
| 6-K | Current report (foreign issuer) | Aug 8, 2023 | Aug 8, 2023 |
| 6-K | Current report (foreign issuer) | Jun 29, 2023 | Jun 29, 2023 |
| 6-K | Current report (foreign issuer) | Jun 27, 2023 | Jun 27, 2023 |
| 6-K | Current report (foreign issuer) | May 18, 2023 | Jun 28, 2023 |
| 6-K | Current report (foreign issuer) | May 15, 2023 | Mar 31, 2023 |
| 6-K | Current report (foreign issuer) | Mar 29, 2023 | Mar 29, 2023 |
| 20-F | Annual report (foreign issuer) | Mar 29, 2023 | Dec 31, 2022 |
| 6-K | Current report (foreign issuer) | Mar 7, 2023 | Mar 7, 2023 |
| 6-K | Current report (foreign issuer) | Jan 17, 2023 | Jan 17, 2023 |
| 6-K | Current report (foreign issuer) | Dec 12, 2022 | Dec 12, 2022 |
| 6-K | Current report (foreign issuer) | Nov 14, 2022 | Nov 14, 2022 |
| 6-K | Current report (foreign issuer) | Nov 10, 2022 | Sep 30, 2022 |
| 6-K | Current report (foreign issuer) | Nov 7, 2022 | Nov 7, 2022 |
| 6-K | Current report (foreign issuer) | Oct 26, 2022 | Oct 26, 2022 |
| 6-K | Current report (foreign issuer) | Oct 25, 2022 | Oct 25, 2022 |
| 6-K | Current report (foreign issuer) | Oct 3, 2022 | Oct 3, 2022 |
| 6-K | Current report (foreign issuer) | Sep 28, 2022 | Sep 28, 2022 |
| 6-K | Current report (foreign issuer) | Aug 10, 2022 | Jun 30, 2022 |
| 6-K | Current report (foreign issuer) | Aug 3, 2022 | Aug 3, 2022 |
| 6-K | Current report (foreign issuer) | Jun 29, 2022 | Jun 29, 2022 |
| 6-K | Current report (foreign issuer) | Jun 27, 2022 | Jun 27, 2022 |
| 6-K | Current report (foreign issuer) | Jun 9, 2022 | Jun 9, 2022 |
| SUPPL | Filing | Jun 9, 2022 | — |
| 6-K | Current report (foreign issuer) | May 24, 2022 | May 24, 2022 |
| 6-K | Current report (foreign issuer) | May 19, 2022 | May 19, 2022 |
| 6-K | Current report (foreign issuer) | May 17, 2022 | May 17, 2022 |
| 6-K | Current report (foreign issuer) | May 16, 2022 | May 16, 2022 |
| 40-F/A | Amended annual report (Canadian issuer) | Apr 20, 2022 | Dec 31, 2021 |
| 6-K | Current report (foreign issuer) | Mar 24, 2022 | Mar 24, 2022 |
| 40-F | Annual report (Canadian issuer) | Mar 24, 2022 | Dec 31, 2021 |
| 6-K | Current report (foreign issuer) | Mar 22, 2022 | Mar 22, 2022 |
| 6-K | Current report (foreign issuer) | Mar 15, 2022 | Mar 15, 2022 |
| 6-K | Current report (foreign issuer) | Mar 1, 2022 | Mar 1, 2022 |
| 6-K | Current report (foreign issuer) | Feb 8, 2022 | Feb 8, 2022 |
| SUPPL | Filing | Feb 8, 2022 | — |
| F-10POS | Filing | Feb 8, 2022 | — |
| F-10/A | Filing | Feb 8, 2022 | — |
| F-X | Filing | Jan 26, 2022 | — |
| F-10 | Filing | Jan 26, 2022 | — |
| 6-K | Current report (foreign issuer) | Jan 19, 2022 | Jan 19, 2022 |
| S-8 | Employee stock plan registration | Jan 18, 2022 | — |
| S-8 POS | Filing | Jan 18, 2022 | — |
| 6-K | Current report (foreign issuer) | Nov 15, 2021 | Nov 15, 2021 |
| 6-K | Current report (foreign issuer) | Nov 9, 2021 | Nov 9, 2021 |
| 6-K | Current report (foreign issuer) | Nov 5, 2021 | Nov 5, 2021 |
| SUPPL | Filing | Nov 4, 2021 | — |
| 6-K | Current report (foreign issuer) | Nov 4, 2021 | Nov 3, 2021 |
| SUPPL | Filing | Nov 4, 2021 | — |
| 6-K | Current report (foreign issuer) | Nov 2, 2021 | Nov 1, 2021 |
| SUPPL | Filing | Nov 2, 2021 | — |
| 6-K | Current report (foreign issuer) | Oct 25, 2021 | Oct 25, 2021 |
| 6-K | Current report (foreign issuer) | Oct 18, 2021 | Oct 18, 2021 |
| 6-K | Current report (foreign issuer) | Sep 16, 2021 | Sep 16, 2021 |
| 6-K | Current report (foreign issuer) | Sep 10, 2021 | Sep 10, 2021 |
| 6-K | Current report (foreign issuer) | Sep 7, 2021 | Sep 7, 2021 |
| 6-K | Current report (foreign issuer) | Sep 2, 2021 | Sep 2, 2021 |
| 6-K | Current report (foreign issuer) | Aug 24, 2021 | Aug 24, 2021 |
| S-8 | Employee stock plan registration | Aug 19, 2021 | — |
| 6-K | Current report (foreign issuer) | Aug 17, 2021 | Aug 16, 2021 |
| CERT | 8a cert | Aug 10, 2021 | — |
| 8-A12B/A | Form 8-a12b/a | Aug 9, 2021 | — |
| 6-K | Current report (foreign issuer) | Aug 9, 2021 | Aug 9, 2021 |
| EFFECT | Filing | Aug 4, 2021 | — |
| 8-A12B | Form 8-a12b | Aug 4, 2021 | — |
| F-10/A | Filing | Aug 3, 2021 | — |
| F-X | Filing | Jul 8, 2021 | — |
| F-10 | Filing | Jul 8, 2021 | — |
| D | Filing | Dec 15, 2020 | — |
| D | Filing | Jan 4, 2019 | — |
| D | Filing | Sep 29, 2017 | — |
| D | Filing | Mar 29, 2017 | — |
Showing 178 filings. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.
New to this? Read What Are SEC Filings? 10-K, 10-Q, 8-K and Other Forms Explained.
Company profile
- Industry
- Biological Products, (No Diagnostic Substances) (SIC 2836)
- Listed as
- CRDL (Nasdaq)
- Fiscal year ends
- December 31
- Incorporated in
- Ontario, Canada
- Headquarters
- Oakville, Ontario, Canada
- SEC filer status
- , Emerging growth company
- SEC CIK
- 1702123
Other Biological Products, (No Diagnostic Substances) companies
- Amgen Inc AMGN
- Gilead Sciences, Inc. GILD
- Moderna, Inc. MRNA
- Argenx SE ARGX
- Revolution Medicines, Inc. RVMD
- Biogen Inc. BIIB
- BioNTech SE BNTX
- Exelixis, Inc. EXEL
All 182 Biological Products, (No Diagnostic Substances) companies
Source: SEC EDGAR filings. This is company-reported data, not investment advice.